KATHERINE BAKER: Open Payments
NPI 1124612619 · WYOMING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 60 payments from 13 companies in 2025. Trend: 2023 $823 · 2024 $1,064 · 2025 $1,063
Food & beverage: $979Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $278 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $193 |
| Janssen Biotech, Inc. | 5 | $169 |
| Phathom Pharmaceuticals, Inc. | 5 | $86 |
| Lilly USA, LLC | 3 | $63 |
| Celltrion USA Inc. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Madrigal Pharmaceuticals | 2 | $43 |
| Ardelyx, Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: ENTYVIO, TREMFYA, CREON, RINVOQ, VOQUEZNA, VEGZELMA, IQIRVO, OMVOH.
Industry payments across MI — which companies pay providers there.
